U.S. market Closed. Opens in 5 hours 57 minutes

FENC | Fennec Pharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-06-302003-06-302002-06-302001-06-302000-06-30
Revenue21.64M1.53MN/A170.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A00
Cost of Revenue1.28M86.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-55.23KN/A
Gross Profit20.36M1.45MN/A170.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A55.23KN/A
Operating Expenses33.36M24.04M17.22M18.05M13.01M10.41M6.95M2.87M1.89M2.88M1.93M3.62M3.44M4.60M2.83M13.89M14.19MN/A18.35MN/AN/AN/A2.70MN/A
Selling, General & Admin33.31M20.51M12.24M12.95M7.40M5.40M5.01M2.40M1.63M2.52M1.33M1.54M1.94M3.90M1.21M3.52M3.28M2.88M3.18M3.49M1.78M907.40K738.72K614.25K
Research & Development57.03K3.53M4.98M5.11M5.61M5.01M1.94M472.00K256.00K357.00K597.00K2.08M1.49M708.00K2.11M10.37M10.91M14.00M12.44M3.59M3.55M3.13M1.91M939.36K
Other Operating Expenses287.00KN/AN/A-9.00K-17.00K6.00K-8.00KN/AN/AN/AN/AN/AN/AN/A-497.00KN/AN/AN/A2.72MN/AN/AN/A55.23KN/A
Operating Income-13.01M-22.59M-17.22M-17.89M-13.01M-10.41M-6.95M-2.87M-1.89M-2.88M-1.93M-3.62M-3.44M-4.60M-2.83M-13.89M-14.19M-19.06M-18.35M-9.42M-6.74M-4.04M-2.65M-1.61M
Other Expenses / Income-3.33M-1.12M-123.00K-224.00K234.00K173.00K-142.00K82.00K1.23M701.00K3.78M-1.54M8.12M-3.25M-229.00KN/AN/A-1.57M-3.19M-171.14K79.44K321.36K194.17K8.31K
Before Tax Income-16.34M-23.71M-17.35M-18.11M-12.78M-9.89M-7.05M-2.79M-659.00K-2.18M1.84M-5.16M4.68MN/AN/AN/AN/A-20.64M-21.54M-9.59M-6.67MN/AN/AN/A
Income Tax Expenses1.001.12M110.00K-187.00K-315.00K-348.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-1.53M-2.29M-854.68K-518.20KN/AN/AN/A
Net Income-16.34M-24.84M-17.46M-17.92M-12.46M-9.89M-7.05M-2.79M-659.00K-2.18M1.84M-5.16M4.68M-7.82M-3.01M-13.60M-13.36M-19.10M-19.25M-8.74M-6.15M-3.72M-2.45M-1.60M
Interest Expenses3.39M978.00K126.00K9.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A11.00KN/AN/AN/AN/AN/A
Basic Shares Outstanding26.57M26.27M26.01M23.70M19.90M19.02M15.01M12.77M10.83M9.87M9.72M8.39M7.99M6.91M3.07M3.07M2.79M1.14M941.26K580.75K309.64K192.51K122.02K536.64K
Diluted Shares Outstanding26.57M26.27M26.01M23.70M19.90M19.02M15.01M12.77M10.83M9.87M10.57M8.39M8.02M6.91M3.07M3.07M2.79M1.14M941.26K2.63M1.42M962.54K607.09K536.64K
EBITDA-13.01M-22.54M-17.18M-17.98M-13.01M-10.58M-7.05M-2.96M-3.12M-3.58M-1.93M-3.60M-3.40M-1.35M-2.60M-13.72M-14.00M-14.61M-14.93M-6.90M-5.22M-4.24M-2.40M-1.55M
EBITDA Margin-60.09%-1,468.60%0.00%-10,579.41%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-363,153,001.68%-228,703,084.30%
EBIT-12.95M-22.74M-17.22M-18.10M-12.78M-10.24M-7.05M-2.79M-659.00K-2.18M1.84M-5.16M4.68M-7.82M-3.01M-13.60M-13.36M-20.64M-21.52M-9.59M-6.67M-3.72M-2.45M-1.60M
EBIT Margin-59.82%-1,481.17%0.00%-10,647.06%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-371,512,604.02%-236,400,367.04%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-06-302003-06-302002-06-302001-06-302000-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙